CABASER Side Effects

6962820-9 | Erythromelalgia
on Aug 25, 2010 Male patient from JAPAN , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: erythromelalgia. Cabaser dosage: Unk. During the same period patient was treated with L DOPA (Unk) (View L-dopa Review and L-dopa Label ).

6856399-X | Insomnia, Obsessive-compulsive Disorder, Psychotic Disorder
Patient was taking Cabaser (View Usage). Patient had the following side effects: insomnia, obsessive-compulsive disorder (What is obsessive-compulsive disorder?), psychotic disorder (What is psychotic disorder?) on Jul 08, 2010 from AUSTRALIA Additional patient health information: Female patient , 32 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: Unk. During the same period patient was treated with SINEMET (5 Times/day) (View Sinemet Review and Sinemet Label ).

6820438-2 | Lymphocyte Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jun 25, 2010 by a Female patient taking Cabaser (View Usage) (Dosage: 2 Mg, 1x/day) . Location: JAPAN , 87 years of age, weighting 121.3 lb, After Cabaser was administered, patient had the following side effects: lymphocyte count decreased, white blood cell count decreased. During the same period patient was treated with MENESIT (150 Mg, 3x/day) (View Menesit Review and Menesit Label ), DOPS (100 Mg, 3x/day) (View Dops Review and Dops Label ), MUCOSTA (100 Mg, 3x/day) (View Mucosta Review and Mucosta Label ), MAGNESIUM OXIDE (250 Mg, 2x/day) (View Magnesium Oxide Review and Magnesium Oxide Label ).

6812610-2 | Blood Albumin Decreased, Oedema Peripheral, Parkinson's Disease
on Jun 21, 2010 Female patient from JAPAN , 62 years of age, weighting 112.2 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), hypertension, type 1 diabetes mellitus, glaucoma (What is glaucoma?) and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, oedema peripheral, parkinson's disease (What is parkinson's disease?). Cabaser dosage: 2 Mg, 1x/day. During the same period patient was treated with AZULFIDINE (Unk) (View Azulfidine Review and Azulfidine Label ), AMLODIPINE BESILATE (5 Mg, 1x/day) (View Amlodipine Besilate Review and Amlodipine Besilate Label ), HUMALOG (Unk) (View Humalog Review and Humalog Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ), MICARDIS (80 Mg, 1x/day) (View Micardis Review and Micardis Label ), CARBIDOPA AND LEVODOPA (5 Times Daily) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), CARTEOLOL HYDROCHLORIDE (Unk) (View Carteolol Hydrochloride Review and Carteolol Hydrochloride Label ). Patient was hospitalized.


6781170-7 | Insomnia, Obsessive-compulsive Disorder
on Jun 09, 2010 Female patient from AUSTRALIA , 37 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient had the following side effects: insomnia, obsessive-compulsive disorder (What is obsessive-compulsive disorder?). Cabaser dosage: Unk.

6764392-0 | Erythromelalgia
Patient was taking Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: erythromelalgia on Jun 02, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: Unk. During the same period patient was treated with L DOPA (Unk) (View L-dopa Review and L-dopa Label ).

6751924-1 | Affect Lability, Agitation, Aortic Valve Disease, Aortic Valve Incompetence, Cough, Dizziness, Dyskinesia, Dyspepsia
Adverse event was reported on May 20, 2010 by a Male patient taking Cabaser (View Usage) (Dosage: 1 Mg, 1x/day) was diagnosed with restless legs syndrome, hyperlipidaemia and. Location: UNITED KINGDOM , 61 years of age, Patient experienced the following unwanted or unexpected effects: affect lability, agitation, aortic valve disease, aortic valve incompetence, cough, dizziness (What is dizziness?), dyskinesia, dyspepsia. During the same period patient was treated with CIPRAMIL (Unk) (View Cipramil Review and Cipramil Label ), CLONAZEPAM (500 Ug, 2x/day) (View Clonazepam Review and Clonazepam Label ), ATORVASTATIN (40 Mg, 1x/day) (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6722572-4 | Eczema, Oedema
on Apr 30, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient had the following side effects: eczema (What is eczema?), oedema. Cabaser dosage: 2 Mg, 1x/day. During the same period patient was treated with AZULFIDINE (View Azulfidine Review and Azulfidine Label ). Patient was hospitalized.

6644788-8 | Erectile Dysfunction
on Mar 09, 2010 Male patient from UNITED KINGDOM , 70 years of age, weighting 238.1 lb, was diagnosed with muscle spasms, restless legs syndrome, hypertension, blood cholesterol increased and was treated with Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: erectile dysfunction (What is erectile dysfunction?). Cabaser dosage: 1 Mg, Unk. During the same period patient was treated with ATENOLOL (50 Mg, Unk) (View Atenolol Review and Atenolol Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Unk) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), SIMVASTATIN (300 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), QUININE SULFATE (300 Mg, Unk) (View Quinine Sulfate Review and Quinine Sulfate Label ).

6628428-X | Erectile Dysfunction
Patient was taking Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: erectile dysfunction (What is erectile dysfunction?) on Feb 26, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 70 years of age, weighting 238.1 lb, was diagnosed with muscle spasms, restless legs syndrome, hypertension, blood cholesterol increased and. Cabaser dosage: 1 Mg, Unk. During the same period patient was treated with ATENOLOL (50 Mg, Unk) (View Atenolol Review and Atenolol Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Unk) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), SIMVASTATIN (300 Mg, Unk) (View Simvastatin Review and Simvastatin Label ).

6610579-7 | Pleurisy
Adverse event was reported on Feb 17, 2010 by a Female patient taking Cabaser (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 75 years of age, Patient had the following side effects: pleurisy. Patient was hospitalized.

6606521-5 | Bradykinesia, Gait Disturbance, Liver Disorder
on Feb 16, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: bradykinesia, gait disturbance, liver disorder. Cabaser dosage: . During the same period patient was treated with GLUTATHIONE (View Glutathione Review and Glutathione Label ), ENTACAPONE (View Entacapone Review and Entacapone Label ), L DOPA (Unk) (View L-dopa Review and L-dopa Label ). Patient was hospitalized.

6566224-2 | Heart Valve Incompetence, Sick Sinus Syndrome
on Jan 20, 2010 Male patient from JAPAN , 82 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: heart valve incompetence, sick sinus syndrome. Cabaser dosage: . During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ). Patient was hospitalized.

6519995-5 | Bedridden, Fall, Fracture, Hallucination
Patient was taking Cabaser (View Usage). Patient had the following side effects: bedridden, fall (What is fall?), fracture (What is fracture?), hallucination on Dec 14, 2009 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: 1 Mg, 3x/day. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ).

6491344-0 | Hallucination
Adverse event was reported on Nov 30, 2009 by a Female patient taking Cabaser (View Usage) (Dosage: 1 Mg, 3x/day) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 85 years of age, After Cabaser was administered, patient had the following side effects: hallucination. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ).

6470394-4 | Aortic Valve Incompetence, Cardiac Valve Disease, Cardiomegaly, Mitral Valve Incompetence, Oedema
on Nov 24, 2009 Female patient from JAPAN , 61 years of age, was diagnosed with parkinsonism, hypertension and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve incompetence, cardiac valve disease, cardiomegaly, mitral valve incompetence, oedema. Cabaser dosage: 3mg/day. During the same period patient was treated with MENESIT (View Menesit Review and Menesit Label ), LONGES (Unk) (View Longes Review and Longes Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ).

6467836-7 | Hallucination
on Nov 19, 2009 Female patient from JAPAN , 85 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient had the following side effects: hallucination. Cabaser dosage: 3 Mg/day. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ).

6423348-8 | Impulsive Behaviour, Paranoia, Sexual Dysfunction
Patient was taking Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: impulsive behaviour, paranoia, sexual dysfunction on Oct 19, 2009 from IRELAND Additional patient health information: Female patient , 43 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: 6 Mg, Unk. During the same period patient was treated with SINEMET CR (View Sinemet Cr Review and Sinemet Cr Label ).

6402048-4 | Heart Valve Incompetence, Myocardial Infarction
Adverse event was reported on Oct 03, 2009 by a Female patient taking Cabaser (View Usage) (Dosage: ) . Location: AUSTRALIA , 75 years of age, Patient experienced the following unwanted or unexpected effects: heart valve incompetence, myocardial infarction.

6380732-9 | Angina Pectoris, Aortic Valve Incompetence, Dyspnoea
on Sep 16, 2009 Female patient from DENMARK , 67 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient had the following side effects: angina pectoris, aortic valve incompetence, dyspnoea. Cabaser dosage: . During the same period patient was treated with SIFROL (View Sifrol Review and Sifrol Label ).

6366698-6 | Aortic Valve Sclerosis
on Sep 22, 2008 Female patient from DENMARK , 57 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: aortic valve sclerosis. Cabaser dosage: Unk. During the same period patient was treated with STOCRIN (View Stocrin Review and Stocrin Label ), COMBIVIR (View Combivir Review and Combivir Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), MADOPAR (View Madopar Review and Madopar Label ), COMTESS (View Comtess Review and Comtess Label ).

6354783-4 | Aortic Valve Sclerosis
Patient was taking Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve sclerosis on Sep 01, 2009 from DENMARK Additional patient health information: Female patient , 58 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: Unk. During the same period patient was treated with STOCRIN (View Stocrin Review and Stocrin Label ), COMBIVIR (View Combivir Review and Combivir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MADOPAR (View Madopar Review and Madopar Label ), COMTESS (View Comtess Review and Comtess Label ).

6335587-5 | Heart Valve Incompetence, Myocardial Infarction
Adverse event was reported on Aug 19, 2009 by a Female patient taking Cabaser (View Usage) (Dosage: ) . Location: AUSTRALIA , 75 years of age, Patient had the following side effects: heart valve incompetence, myocardial infarction.

6298819-8 | Interstitial Lung Disease, Pulmonary Fibrosis
on Jul 24, 2009 Female patient from JAPAN , 83 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?). Cabaser dosage: .

6297307-2 | Confusional State, Dysarthria, Salivary Hypersecretion, Somnolence
on Jul 24, 2009 Female patient from SWITZERLAND , 68 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, dysarthria, salivary hypersecretion, somnolence. Cabaser dosage: 2 Mg, 3x/day. During the same period patient was treated with MADOPAR (125 Mg, 3x/day) (View Madopar Review and Madopar Label ). Patient was hospitalized.

6236130-1 | Hallucination, Pneumonia
Patient was taking Cabaser (View Usage). Patient had the following side effects: hallucination, pneumonia (What is pneumonia?) on Jun 09, 2009 from JAPAN Additional patient health information: Female patient , 73 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: . During the same period patient was treated with MENESIT (View Menesit Review and Menesit Label ). Patient was hospitalized.

6231992-6 | Ear Disorder, Visual Impairment
Adverse event was reported on Jun 04, 2009 by a Female patient taking Cabaser (View Usage) (Dosage: ) . Location: JAPAN , 88 years of age, After Cabaser was administered, patient had the following side effects: ear disorder, visual impairment. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), PURSENNID (View Pursennid Review and Pursennid Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ), BIO THREE (View Bio Three Review and Bio Three Label ), PARIET (View Pariet Review and Pariet Label ).

6220350-6 | Hallucination, Pneumonia
on May 28, 2009 Female patient from JAPAN , 73 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, pneumonia (What is pneumonia?). Cabaser dosage: . During the same period patient was treated with MENESIT (View Menesit Review and Menesit Label ). Patient was hospitalized.

6042531-7 | Atrial Fibrillation, Bronchitis, Cardiac Failure, Cardiac Valve Sclerosis
on Jan 07, 2009 Female patient from ITALY , 60 years of age, was treated with Cabaser (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?), cardiac failure, cardiac valve sclerosis. Cabaser dosage: . Patient was hospitalized.

6024200-2 | Aortic Valve Incompetence, Atrial Fibrillation, Bronchitis, Cardiac Failure, Cardiac Valve Sclerosis, Ejection Fraction Decreased, Mitral Valve Incompetence, Pericardial Effusion, Tricuspid Valve Disease
Patient was taking Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: aortic valve incompetence, atrial fibrillation (What is atrial fibrillation?), bronchitis (What is bronchitis?), cardiac failure, cardiac valve sclerosis, ejection fraction decreased, mitral valve incompetence, pericardial effusion, tricuspid valve disease on Dec 16, 2008 from ITALY Additional patient health information: Female patient , 60 years of age, . Cabaser dosage: . Patient was hospitalized.

5923001-0 | Cardiac Hypertrophy, Cardiac Valve Disease
Adverse event was reported on Oct 07, 2008 by a Female patient taking Cabaser (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 65 years of age, Patient experienced the following unwanted or unexpected effects: cardiac hypertrophy, cardiac valve disease.

5916791-4 | Quality Of Life Decreased
on Oct 02, 2008 Male patient from IRELAND , weighting 168.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient had the following side effects: quality of life decreased. Cabaser dosage: .

5900438-7 | Blood Pressure Decreased, Bradycardia
on Sep 16, 2008 Male patient from JAPAN , weighting 157.6 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: blood pressure decreased, bradycardia. Cabaser dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), EBRANTIL (Daily Dose:60mg) (View Ebrantil Review and Ebrantil Label ), BLOPRESS (View Blopress Review and Blopress Label ), CONIEL (Daily Dose:8mg) (View Coniel Review and Coniel Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5896099-6 | Hypothermia, Joint Swelling, Vomiting
Patient was taking Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: hypothermia (What is hypothermia?), joint swelling, vomiting on Sep 12, 2008 from AUSTRALIA Additional patient health information: Female patient , 19 years of age, . Cabaser dosage: .

5874457-3 | Aplasia, Holoprosencephaly, Pulmonary Hypoplasia
Adverse event was reported on Aug 27, 2008 by a Female patient taking Cabaser (View Usage) (Dosage: ) was diagnosed with hyperprolactinaemia, polycystic ovaries and. Location: JAPAN , weighting 3.58 lb, Patient had the following side effects: aplasia, holoprosencephaly, pulmonary hypoplasia.

5871104-1 | Lymphoma, Pleural Effusion
on Sep 01, 2008 Female patient from JAPAN , weighting 74.96 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: lymphoma (What is lymphoma?), pleural effusion. Cabaser dosage: . During the same period patient was treated with EC DOPARL (View Ec Doparl Review and Ec Doparl Label ), DEPAS (View Depas Review and Depas Label ), ERSIBON (View Ersibon Review and Ersibon Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), RIZE (View Rize Review and Rize Label ). Patient was hospitalized.

5865909-0 | Cardiac Failure, Cardiac Valve Disease, Disseminated Intravascular Coagulation, Neuroleptic Malignant Syndrome
on Aug 19, 2008 Female patient from JAPAN , 74 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, cardiac valve disease, disseminated intravascular coagulation, neuroleptic malignant syndrome. Cabaser dosage: . During the same period patient was treated with CARBIDOPA + LEVODOPA (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ). Patient was hospitalized.

5837309-0 | Basedow's Disease, Mitral Valve Incompetence
Patient was taking Cabaser (View Usage). Patient had the following side effects: basedow's disease, mitral valve incompetence on Jul 31, 2008 from JAPAN Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: Text:2-3 Mg. During the same period patient was treated with PERMAX (Daily Dose:750mg) (View Permax Review and Permax Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), ARTANE (View Artane Review and Artane Label ), SIFROL (View Sifrol Review and Sifrol Label ). Patient was hospitalized.

5831609-6 | Posture Abnormal
Adverse event was reported on Jul 23, 2008 by a Male patient taking Cabaser (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 65 years of age, After Cabaser was administered, patient had the following side effects: posture abnormal. During the same period patient was treated with SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), L DOPA (View L-dopa Review and L-dopa Label ), BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), PERGOLIDE MESYLATE (View Pergolide Mesylate Review and Pergolide Mesylate Label ), DROXIDOPA (View Droxidopa Review and Droxidopa Label ).

5826190-1 | Basedow's Disease, Mitral Valve Incompetence
on Jul 17, 2008 Male patient from JAPAN , weighting 119.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: basedow's disease, mitral valve incompetence. Cabaser dosage: Text:2-3 Mg. During the same period patient was treated with PERMAX (Daily Dose:750mg) (View Permax Review and Permax Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), ARTANE (View Artane Review and Artane Label ), SIFROL (View Sifrol Review and Sifrol Label ). Patient was hospitalized.

5823584-5 | Mitral Valve Incompetence
on Jul 15, 2008 Female patient from JAPAN , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient had the following side effects: mitral valve incompetence. Cabaser dosage: . During the same period patient was treated with MENESIT (View Menesit Review and Menesit Label ).

5815430-0 | Blood Pressure Decreased, Bradycardia
Patient was taking Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: blood pressure decreased, bradycardia on Jul 07, 2008 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: . During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), NORVASC (View Norvasc Review and Norvasc Label ), BLOPRESS (View Blopress Review and Blopress Label ), CONIEL (View Coniel Review and Coniel Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5809115-4 | Cardiac Hypertrophy, Cardiac Valve Disease
Adverse event was reported on Jul 04, 2008 by a Female patient taking Cabaser (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 65 years of age, Patient experienced the following unwanted or unexpected effects: cardiac hypertrophy, cardiac valve disease.

5797204-2 | Hyponatraemia
on Jun 19, 2008 Female patient from JAPAN , 96 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient had the following side effects: hyponatraemia. Cabaser dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), CONIEL (View Coniel Review and Coniel Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5788261-8 | Cardiac Hypertrophy, Cardiac Valve Disease
on Jun 13, 2008 Female patient from JAPAN , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: cardiac hypertrophy, cardiac valve disease. Cabaser dosage: .

5775624-X | Basedow's Disease, Mitral Valve Incompetence
Patient was taking Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: basedow's disease, mitral valve incompetence on Jun 09, 2008 from JAPAN Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: Text:2-3 Mg. During the same period patient was treated with PERMAX (Daily Dose:750mg) (View Permax Review and Permax Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), ARTANE (View Artane Review and Artane Label ), SIFROL (View Sifrol Review and Sifrol Label ). Patient was hospitalized.

5763231-4 | Basedow's Disease, Mitral Valve Incompetence
Adverse event was reported on May 28, 2008 by a Male patient taking Cabaser (View Usage) (Dosage: Text:2-3 Mg) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , weighting 119.0 lb, Patient had the following side effects: basedow's disease, mitral valve incompetence. During the same period patient was treated with SYMMETREL (View Symmetrel Review and Symmetrel Label ), ARTANE (View Artane Review and Artane Label ), SIFROL (View Sifrol Review and Sifrol Label ). Patient was hospitalized.

5726905-7 | Eyelid Ptosis
on Apr 24, 2008 Female patient from JAPAN , 75 years of age, was treated with Cabaser (View Usage). After Cabaser was administered, patient had the following side effects: eyelid ptosis. Cabaser dosage: Daily Dose:2mg.

5397206-4 | Aortic Valve Incompetence, Cardiac Murmur, Dyspnoea, Mitral Valve Incompetence
on Jul 13, 2007 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabaser (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve incompetence, cardiac murmur, dyspnoea, mitral valve incompetence. Cabaser dosage: . During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

5395770-2 | Depression, Pathological Gambling
Patient was taking Cabaser (View Usage). Patient had the following side effects: depression (What is depression?), pathological gambling on Jul 12, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, weighting 187.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabaser dosage: . During the same period patient was treated with NARATRIPTAN (View Naratriptan Review and Naratriptan Label ), CO BENELDOPA (View Co-beneldopa Review and Co-beneldopa Label ), CO CARELDOPA (View Co-careldopa Review and Co-careldopa Label ).